Medium chain acyl CoA dehydrogenase deficiency

From WikiMD's Wellness Encyclopedia

Medium Chain Acyl-CoA Dehydrogenase Deficiency Medium Chain Acyl-CoA Dehydrogenase Deficiency (MCADD) is a rare genetic disorder that affects the body's ability to break down medium-chain fatty acids into energy. This condition is part of a group of disorders known as fatty acid oxidation disorders.

Overview[edit | edit source]

MCADD is caused by mutations in the ACADM gene, which provides instructions for making an enzyme called medium-chain acyl-CoA dehydrogenase. This enzyme is essential for the oxidation of medium-chain fatty acids, a crucial step in the process of converting fat into energy, especially during periods of fasting.

Symptoms[edit | edit source]

Symptoms of MCADD typically appear in infancy or early childhood and can include:

  • Hypoglycemia (low blood sugar)
  • Lethargy
  • Vomiting
  • Seizures
  • Coma

If untreated, MCADD can lead to serious complications such as liver problems, brain damage, or even sudden death.

Diagnosis[edit | edit source]

MCADD is often diagnosed through newborn screening programs, which test for elevated levels of certain metabolites in the blood. Confirmatory testing involves genetic testing to identify mutations in the ACADM gene.

Treatment[edit | edit source]

Management of MCADD involves:

  • Avoiding fasting
  • Maintaining a regular feeding schedule
  • Providing a high-carbohydrate, low-fat diet
  • Supplementing with carnitine in some cases

Genetics[edit | edit source]

MCADD is inherited in an autosomal recessive pattern, meaning that an individual must inherit two copies of the mutated gene, one from each parent, to be affected by the disorder.

Epidemiology[edit | edit source]

MCADD is one of the more common fatty acid oxidation disorders, with an estimated incidence of 1 in 10,000 to 1 in 20,000 live births in the United States.

See Also[edit | edit source]

,

 Medium Chain Acyl-CoA Dehydrogenase Deficiency: A Review, 
 Journal of Rare Diseases, 
 2020, 
 Vol. 15(Issue: 3), 
 pp. 123-130,

Emily,

 Inherited Metabolic Disorders, 
  
 New York:Medical Press, 
 2018,

External Links[edit | edit source]

NIH genetic and rare disease info[edit source]

Medium chain acyl CoA dehydrogenase deficiency is a rare disease.

WikiMD
Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Search WikiMD

Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD

WikiMD's Wellness Encyclopedia

Let Food Be Thy Medicine
Medicine Thy Food - Hippocrates

Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.

Contributors: Prab R. Tumpati, MD